Israel Expands Non-Small Cell Lung Cancer Testing Coverage
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read More
Search Results for: lung cancer
Merus, Caris Life Sciences Collaborate to Detect NRG1 Fusions in Cancer Patients
Caris will provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial.
Read MoreGuardant Health, Janssen to Develop Liquid Biopsy Companion Diagnostic
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.
Read More
Detecting Varicella-Zoster Virus
A new identification reagent speeds diagnoses of chickenpox and shingles.
Read More
Advances in Liquid Biopsy
Mastering tumor heterogeneity to unlock personalized medicine
Read More